INTRODUCTION
Cerebrovascular disease is a major cause of morbidity and mortality around the world. 1, 2 In Hong Kong, cerebrovascular disease was the fourth leading cause of death and there were 26,487 related in-patient discharges in 2011. 3 Although the prevalence of extracranial carotid artery stenosis was shown to be much lower in the Asian population when compared with the Caucasians, 4 it remains an important and treatable cause of stroke.
Radiation has been shown to induce changes similar to atherosclerosis. 5 Patients who receive radiotherapy to the head and neck regions have a high risk of developing significant carotid artery stenosis. 6 Given the endemicity of nasopharyngeal carcinoma in the southern Chinese, 7 radiation-associated carotid artery stenosis is relatively common in Hong Kong. Due to the high risk of carotid endarterectomy in radiation-associated carotid stenosis, 8 transluminal angioplasty and stenting have become widely accepted treatment alternatives in this group of patients. However, there are only a few studies on the clinical outcomes of carotid angioplasty and stenting (CAS) in radiation-associated stenosis. The objective of this retrospective study was to investigate the procedural complication rate, restenosis rate, and clinical outcomes after CAS in patients with radiationassociated carotid stenosis.
METHODS

Patient Population
All patients with a history of head and/or neck radiation referred to Queen Elizabeth Hospital, Hong Kong, for CAS for carotid artery stenosis between January 2008 and December 2013 were identified. Clinical information was assessed using electronic patient records (ePRs). Procedural and imaging findings were retrieved with both ePRs and Picture Archiving and Communication System. All preoperative clinical assessments were performed by either a neurosurgeon or a vascular surgeon experienced in endovascular interventions. 
Procedures
All procedures were performed by a dedicated team of neurointerventionists with at least one experienced operator who had performed more than 10 CAS procedures per year in the past 2 years. The procedures were undertaken in a biplanar neuroangiographic suite or an endovascular operating room. Diagnostic carotid angiograms were performed on ipsilateral carotid arteries to grade the internal carotid artery (ICA) or common carotid artery (CCA) stenosis according to the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria. 9 Transfemoral approaches under local anaesthesia were used for all CAS procedures. All CAS procedures were performed using the Carotid WALLSTENT Monorail Endoprosthesis system (Boston Scientific, Massachusetts, US). Embolic protection devices with FilterWire EZ (Boston Scientific, Massachusetts, US) were used at the discretion of the operators. Peri-procedural drug therapy included a combination of antiplatelet medications plus aspirin (80/160 mg daily started at least 5 days preoperatively and continued indefinitely after CAS), clopidogrel (75 mg daily started at least 5 days preoperatively and continued at least 3 months after CAS) and intra-operative heparinisation (with target activated clotting time of 250-300 s).
Postoperative Follow-up
Neurological assessments were performed by neurosurgeons or vascular surgeons immediately after the procedure, at discharge, at 1 month after CAS, and thereafter at 3 to 6 months, at 12 months and once every year. Opportunistic assessments were performed when the patients attended clinics or were admitted to our hospital or other network hospitals in Hong Kong.
As per protocol, imaging follow-up using Doppler ultrasound was performed at post-procedural day 1, at 3 months, 6 months, 12 months, and then once every year, if the patient was asymptomatic. Ad-hoc Doppler ultrasound was performed when a neurological event developed. Doppler ultrasound criteria proposed by
Robbin et al
10 were used to screen for significant restenosis. Diagnostic carotid angiograms were subsequently performed to confirm significant (>70%) restenosis.
Statistical Analysis
Event-free survival (defined as absence of ipsilateral ischaemic event and restenosis), ipsilateral ischaemic event-free survival, and restenosis-free survival were assessed for the 45 stented vessels. Ischaemic events included cerebral infarcts and transient ischaemic attacks. Restenosis was defined as a diameter reduction of >70% by NASCET criteria. Cumulative survival was calculated using Kaplan-Meier analysis. The Statistical Package for the Social Sciences (Windows version 16.0; SPSS Inc, Chicago [IL], US) was used to perform the statistical analysis.
RESULTS
Patient Characteristics
A total of 61 procedures were identified during the study period. Eleven CAS procedures for restenosis were excluded. Two were excluded due to insignificant irradiation to carotid arteries by radioactive iodine for hyperthyroidism. Three procedures were abandoned and excluded because CAS was regarded technically unfeasible as intra-procedural diagnostic carotid angiograms showed total occlusion of the target carotid arteries.
Forty-five carotid arteries in 40 patients (32 men and 8 women) were stented in this study. Five patients had bilateral stenosis which had been managed with interventional therapy: bilateral CAS had been performed in one single session in two patients and as two-staged procedures in three patients. The mean (± standard deviation) age was 63.3 (± 8.3) years (range, 48-78 years). Of the 40 patients, 35 (87.5%) had at least one cardiovascular risk factor. Nasopharyngeal carcinoma was the most frequent head and neck cancer in this study group (n=36; 90.0%). The mean time interval between radiotherapy and CAS was 228.8 ± 100.2 months (range, 8-487 months). Majority of CAS procedures (36/40, 90.0%) were performed for symptomatic stenosis. Patient demographic and characteristics are summarised in Table 1 .
Carotid Angioplasty and Stenting
Characteristics of the CAS procedures are summarised in Table 2 . Contralateral carotid artery occlusions were noted during 14 (31.1%) CAS procedures. Embolic protection devices were used in 37 (82.2%) procedures. One stent was deployed in 36 (80.0%) procedures. The stents were placed across carotid bifurcations in 33 (73.3%) procedures. Significant residual stenosis, defined as >20% by NASCET criteria, was found in four procedures, accounting for an overall technical success rate of 91.1%.
Early Outcome
There was one (2.2%) procedural complication, with dissection of the left CCA during catheterization for left ICA stenting (Figure 1 ). It was not associated with additional haemodynamic disturbance or intra-operative stroke. The stenosis and the dissection flap were covered with a total of three Wallstents.
No patient died during the 30-day postoperative period. Three 30-day postoperative neurological events occurred in the 45 CAS procedures, accounting for a postoperative complication rate of 6.7%. These included two cases of minor subarachnoid haemorrhage (SAH) occurring on postoperative day 1 and day 6. The SAH resolved spontaneously in both patients after temporary withholding of the double antiplatelet medications, leaving no added neurological sequelae. One patient had ipsilateral transient ischaemic attack on postoperative day 3 after his left ICA stenting. There was no other postoperative morbidity such as seizure or groin haematoma.
Long-term Outcome
Follow-up was available for 44 vessels in 39 patients (one patient was lost to follow-up after the 1-month postoperative assessment). The mean follow-up period was 29 months (range, 1-66 months). Four Restenosis of >70% (Figure 2 ) was diagnosed in six (13.6%) stented vessels at a mean interval of 17.7 months (range, 3.1-46.7 months) after the procedure. In two of these six cases, restenosis resulted in cerebral infarcts and were symptomatic. The remaining four cases with restenosis were asymptomatic. A second CAS procedure was performed on four cases with restenosis. After the second CAS, two patients were asymptomatic and restenosis-free while one patient died at 15 months and one developed restenosis 10 months after the second CAS. A third CAS procedure was performed on the carotid artery with second restenosis and it was event-free at 11.3 months after the third procedure. Table 3 summarises the outcomes of CAS. Figure 3 illustrates the survival curves of the 45 stented vessels. The event-free survival (defined as absence of ipsilateral ischaemic event and restenosis) rates were 92.8% at 6 months, 87.6% at 1 year, and 70.0% at 5 years. The ipsilateral ischaemic event-free survival rates were 97.8% at 6 months, 95.1% at 1 year, and 84.0% at 5 years. The restenosis-free survival rates were 95.0% at 6 months, 92.5% at 1 year, and 74.0% at 5 years.
DISCUSSION
Carotid stenosis is an important and treatable cause of stroke. In 1991, the NASCET demonstrated that carotid endarterectomy was highly beneficial to patients with symptomatic high-grade ICA stenosis. 9 In the past decade, CAS has evolved as an alternative and is increasingly performed for this indication. There are a few multicentre randomised controlled trials comparing the safety and efficacy of carotid endarterectomy with CAS. The long-term follow-up of the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS) did not demonstrate significant difference in stroke prevention between the two treatments.
11 The International Carotid Stent Study (ICSS) showed that carotid endarterectomy was safer than carotid stenting in the short term.
12 However, endarterectomy was associated with more cranial nerve injuries and more severe haematomas when compared with CAS.
12 Thus, CAS may be beneficial to radiation-associated stenosis due to the absence of neck incision, avoidance of cranial nerve injury, and less wound complications in the irradiated field. 13 Radiation-associated carotid stenosis is a particular concern and relatively common in Hong Kong due to the high prevalence of nasopharyngeal carcinoma in the southern Chinese. 7 Carotid stenosis has been a known, long-term complication after local irradiation for malignant disease. Yet, the pathogenesis of radiation-induced vessel wall damage has not been fully understood. A combination of different mechanisms has been proposed, including ischaemic necrosis of vasa vasorum, adventitial fibrosis, and accelerated atherosclerosis. 6, 14 Recent advances in molecular biology show that the persistent up-regulation of inflammatory markers can be responsible for radiation-induced vascular disease. 15 Nevertheless, traditional cardiovascular risk factors were shown to amplify the hazard of radiationassociated arterial stenosis. 6 We report our experience on CAS for radiationassociated carotid artery stenosis. In our population, 36 (90%) out of 40 patients had a history of irradiation for nasopharyngeal carcinoma, which is the most common head and neck cancer in Hong Kong. 3 With local studies showing the unique features and pattern of involvement of carotid stenosis after radiotherapy for nasopharyngeal carcinoma, 16, 17 this study is different from similar studies performed in Europe and the US where a history of irradiation for laryngeal cancer is more common in patients undergoing CAS. 14, 18 The degree of carotid stenosis correlates with postradiotherapy duration. 6 In our series, the mean interval from radiotherapy to CAS was 228.8 months, which is comparable to a similar published series.
18 Most patients (90%) in our study had cerebrovascular symptoms whereas 78% (14/18) of patients with carotid stenosis in another similar study conducted by Ting et al 19 were symptomatic. The mean interval from radiation to CAS was 144 months in the study by Ting et al. 19 The difference in the time intervals between the two series suggests there may be a potential time lag between the development of significant carotid stenosis and neurological symptoms. Although the optimal management of asymptomatic carotid artery stenosis remains unclear, 20 this suggests that follow-up at closer intervals may provide an opportunity for medical treatment and consideration of earlier intervention in patients with radiation-associated carotid stenosis.
Evidence suggests that radiation-associated carotid artery stenosis is more extensive and involves the long segment of the CCA, which is not a 'typical' location of atherosclerotic lesions. 21 Significant CCA stenosis is also more prevalent in patients with symptoms of cerebrovascular insufficiency. 6 In our study, 24/45 (53%) patients with carotid artery stenosis showed CCA involvement.
With a 2.2% procedural complication rate without permanent neurological sequelae, 0% of procedural stroke rate, 0% of 30-day mortality rate, and 6.7% of 30-day complication rate without permanent neurological sequelae, our results of CAS for radiationassociated carotid stenosis are considered satisfactory, safe, and comparable with CAS in high-surgical-risk patients.
22 Considering long-term ipsilateral ischaemic neurological events, our results are not inferior to the CAVATAS population, with a cumulative 5-year incidence of 16%.
11 This rate is consistent with that from a previous study showing no significant difference in major adverse events between CAS for atherosclerotic and radiation-associated carotid stenosis.
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A unique feature in our study was the high proportion of patients (31.1%) with contralateral carotid artery occlusion which aligns with the rates in other postradiation studies. For example, contralateral carotid artery occlusion rate was 25% in the study by Cheng et al 16 and 12% in the study by Favre et al. 14 This group of patients is often under-represented in large multicentre randomised controlled trials for CAS, including ICSS.
12
As endarterectomies in patients with contralateral carotid occlusions have been reported to have increased perioperative morbidity and mortality, 24 CAS theoretically has the advantages of decreased ischaemia time and avoidance of shunt placement. Furthermore, the procedure is performed without sedation or anaesthesia. However, a recent review concluded that contralateral occlusion is not a clinically important reason for choosing CAS over endarterectomy.
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This study, 25 however, has the drawback of being a retrospective review of a small group of patients (n=57) and short-term follow-up (mean, 28 months). More data are needed for the optimal management in this subgroup of patients.
Cerebral protection devices may decrease the risk of procedural stroke, but evidence is conflicting. Two early multicentre studies, one using Nitinol stent and the SPIDER Embolic Protection System (CREATE Trial) and another one using Wallstent and Filterwire Embolic protection System (BEACH trial) showed that the outcomes in high-surgical-risk patients were promising: CAS using cerebral protection devices was not inferior to endarterectomy. 22, 26 The findings were consistent with those of the SAPPHIRE study. 27 However, data from the ICSS study showed cerebral protection devices did not protect against periprocedural stroke.
28 In our centre, the use of cerebral protection device was at the discretion of the operators, with a utilisation rate of 82.2%. In the recent years, we are in favour of using cerebral protection based on our past observations of captured emboli in the filter after retraction of the devices.
In addition to demonstrating good safety profile, the long-term patency rate of CAS in radiation-associated stenosis was satisfactory in our study. Restenosis, defined as >70% stenosis according to NASCET criteria, had a cumulative incidence rate of 7.5% at 1 year and 26% at 5 years in our study. In comparison, a large retrospective study of CAS for radiationassociated stenosis had a 5-year cumulative restenosis (50% stenosis) rate of 39.8%. 14 In the CAVATAS population, the 5-year cumulative restenosis rates were 16.6 % for >70% stenosis and 36.6% for >50% stenosis. 29 A higher >70% restenosis rate was observed for CAS in radiation-associated stenosis. Despite this discrepancy, the CREST study group showed similar restenosis rates with CAS and endarterectomy.
30
CONCLUSION
We demonstrated that CAS is safe in patients with radiation-associated carotid artery stenosis. The longterm clinical outcomes of ischaemic neurological events and restenosis are satisfactory.
